Leucine supplementation protects from insulin resistance by regulating adiposity levels
2013
Binder , Elke (Institut Naltional de la Santé et de la Recherche Médicale , Bordeaux(France). Neurocentre Magendie, Physiopathologie de la Plasticité Neuronale, U862) | Bermúdez-Silva , Francisco J. (Institut National de la Santé et de la Recherche MédicaleIBIMA-Hospital Carlos Haya, BordeauxMalaga(France). Neurocentre Magendie, Physiopathologie de la Plasticité Neuronale, U862) | André , Caroline (Institut National de la Santé et de la Recherche Médicale, Bordeaux(France). Neurocentre Magendie, Physiopathologie de la Plasticité Neuronale, U862) | Elie , Melissa (Institut National de la Santé et de la Recherche Médicale, Bordeaux(France). Neurocentre Magendie, Physiopathologie de la Plasticité Neuronale, U862) | Romero-Zerbo , Silvana Y. (Institut Naltional de la Santé et de la Recherche Médicale IBIMA-Hospital Carlos Haya, BordeauxMalaga(France). Neurocentre Magendie, Physiopathologie de la Plasticité Neuronale, U862) | Leste-Lasserre , Thierry (Institut National de la Santé et de la Recherche Médicale, Bordeaux(France). Neurocentre Magendie, Physiopathologie de la Plasticité Neuronale, U862) | Belluomo , llaria (Institut Naltional de la Santé et de la Recherche Médicale , Bordeaux(France). Neurocentre Magendie, Physiopathologie de la Plasticité Neuronale, U862) | Duchampt , Adeline (Institut Naltional de la Santé et de la Recherche Médicale , Lyon(France).) | Clark , Samantha (Institut Naltional de la Santé et de la Recherche Médicale , Bordeaux(France). Neurocentre Magendie, Physiopathologie de la Plasticité Neuronale, U862) | Aubert , Agnès (INRA , Bordeaux (France). UMR 1286 Nutrition et Neurobiologie intégrée) | Mezzullo , Marco (Université de Bologne(Italie). Endocrinology Unit and Centro di Ricerca Biomedica Applicata, Department of Clinical Medicine, S.Orsola-Malpighi Hospital) | Fanelli , Flaminia (Université de Bologne(Italie).) | Pagotto , Uberto (Université de Bologne(Italie). Endocrinology Unit and Centro di Ricerca Biomedica Applicata, Department of Clinical Medicine, S.Orsola-Malpighi Hospital) | Layé , Sophie (INRA , Bordeaux (France). UMR 1286 Nutrition et Neurobiologie intégrée) | Mithieux , Gilles (Institut Naltional de la Santé et de la Recherche Médicale , Lyon(France).) | Cota , Daniela (Institut National de la Santé et de la Recherche Médicale, Bordeaux(France). Neurocentre Magendie, Physiopathologie de la Plasticité Neuronale, U862)
Background[br/] Leucine supplementation might have therapeutic potential in preventing diet-induced obesity and improving insulin sensitivity. However, the underlying mechanisms are at present unclear. Additionally, it is unclear whether leucine supplementation might be equally efficacious once obesity has developed.[br/] [br/] Methodology/Principal Findings[br/] Male C57BL/6J mice were fed chow or a high-fat diet (HFD), supplemented or not with leucine for 17 weeks. Another group of HFD-fed mice (HFD-pairfat group) was food restricted in order to reach an adiposity level comparable to that of HFD-Leu mice. Finally, a third group of mice was exposed to HFD for 12 weeks before being chronically supplemented with leucine. Leucine supplementation in HFD-fed mice decreased body weight and fat mass by increasing energy expenditure, fatty acid oxidation and locomotor activity in vivo. The decreased adiposity in HFD-Leu mice was associated with increased expression of uncoupling protein 3 (UCP-3) in the brown adipose tissue, better insulin sensitivity, increased intestinal gluconeogenesis and preservation of islets of Langerhans histomorphology and function. HFD-pairfat mice had a comparable improvement in insulin sensitivity, without changes in islets physiology or intestinal gluconeogenesis. Remarkably, both HFD-Leu and HFD-pairfat mice had decreased hepatic lipid content, which likely helped improve insulin sensitivity. In contrast, when leucine was supplemented to already obese animals, no changes in body weight, body composition or glucose metabolism were observed.[br/] [br/] Conclusions/Significance[br/] These findings suggest that leucine improves insulin sensitivity in HFD-fed mice by primarily decreasing adiposity, rather than directly acting on peripheral target organs. However, beneficial effects of leucine on intestinal gluconeogenesis and islets of Langerhans's physiology might help prevent type 2 diabetes development. Differently, metabolic benefit of leucine supplementation is lacking in already obese animals, a phenomenon possibly related to the extent of the obesity before starting the supplementation.
显示更多 [+] 显示较少 [-]